Abstract

A REVIEW ON NEWER APPROACH IN DENGUE TREATMENT WITH CARIPILL (A LEAF EXTRACT OF CARICA PAPAYA)

A. Bharath Kumar*, T. Mubeena, Y. Charitha and M. Manasa Rekha

ABSTRACT

Dengue is a mosquito reflected viral infection.It comprises of serotypes of species like DEN-1, DEN-2, DEN-3 and DEN-4) which belong to the genus Flavivirus, family Flaviviridae. Once infected with dengue virus humans become central carrier and the virus multiplies serving as a source of the virus for uninfected mosquitoes. The virus circulates in the vascular stream of an infected person for 2-7 days same time that the person develops a fever. The risk for developing infection includes travelling during the rainy season and staying in cities of high-risk countries may develops the infection burden in the community. Once the virus enters affecting the persons the symptoms prone to develop 3 to 14 days. we can investigate the symptoms in infected patients like Bleeding of the gums, nosebleeds, rash, skin discoloration such as bruising, vomiting, loss of appetite, abdominal pain, hematemesis. According to current statistics of WHO each year between 50 and 528 million people are infected with dengue and approximately 10,000 to 20,000 persons were prone to death in the community. Recently micro labs launches caripill drug it is a extract of carica papaya for effective treatment for dengue patients which will boost the rise of platelets count in infected patients. It is a new dimension in dengue treatment.We hope that through these approaches we can minimize the infections in the community.similarly we can minimize the health related burden towards physicians and Patients.

Keywords: Rashes, virus, fever, infection, hematemesis.